(Q45158689)

10 December 2017

title

Transient versus sustained phosphorylation and nuclear accumulation of ERKs underlie anti-versus pro-apoptotic effects of estrogens (English)

1 reference

10 December 2017

1 reference

1 reference

7

Teresita Bellido

1 reference

10 December 2017

Jin-Ran Chen

1

1 reference

10 December 2017

Lilian I Plotkin

2

1 reference

10 December 2017

José Ignacio Aguirre

3

1 reference

10 December 2017

Li Han

4

1 reference

10 December 2017

Robert L Jilka

5

1 reference

10 December 2017

Stavroula Kousteni

6

1 reference

10 December 2017

Stavros C Manolagas

8

1 reference

10 December 2017

language of work or name

English

0 references

publication date

22 November 2004

1 reference

Journal of Biological Chemistry

10 December 2017

number of pages

7

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

10 December 2017

volume

280

1 reference

10 December 2017

issue

6

1 reference

10 December 2017

page(s)

4632-4638

1 reference

Birth and Death of Bone Cells: Basic Regulatory Mechanisms and Implications for the Pathogenesis and Treatment of Osteoporosis 1

10 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411530200

Reversal of bone loss in mice by nongenotropic signaling of sex steroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411530200

Linkage of decreased bone mass with impaired osteoblastogenesis in a murine model of accelerated senescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411530200

Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411530200

Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411530200

Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411530200

Proteasomal degradation of Runx2 shortens parathyroid hormone-induced anti-apoptotic signaling in osteoblasts. A putative explanation for why intermittent administration is needed for bone anabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411530200

Kinase-mediated regulation of common transcription factors accounts for the bone-protective effects of sex steroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411530200

Estrogen promotes apoptosis of murine osteoclasts mediated by TGF-beta.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411530200

Estrogen inhibits bone resorption by directly inducing apoptosis of the bone-resorbing osteoclasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411530200

Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411530200

Prolonged nuclear retention of activated extracellular signal-regulated protein kinase promotes cell death generated by oxidative toxicity or proteasome inhibition in a neuronal cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411530200

ERK activation mediates cell cycle arrest and apoptosis after DNA damage independently of p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411530200

Reduction of c-Src activity by substituted 5,7-diphenyl-pyrrolo[2,3-d]-pyrimidines induces osteoclast apoptosis in vivo and in vitro. Involvement of ERK1/2 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411530200

Mathematical models of protein kinase signal transduction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411530200

Alpha5beta1 integrin controls cyclin D1 expression by sustaining mitogen-activated protein kinase activity in growth factor-treated cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411530200

Sustained MAP kinase activation is required for the expression of cyclin D1, p21Cip1 and a subset of AP-1 proteins in CCL39 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411530200

Sustained activation of extracellular-signal-regulated kinase 1 (ERK1) is required for the continued expression of cyclin D1 in G1 phase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411530200

SB203580 promotes EGF-stimulated early morphological differentiation in PC12 cell through activating ERK pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411530200

Growth factor-induced p42/p44 MAPK nuclear translocation and retention requires both MAPK activation and neosynthesis of nuclear anchoring proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411530200

Phosphorylation of the MAP kinase ERK2 promotes its homodimerization and nuclear translocation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411530200

A short amino acid sequence able to specify nuclear location

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411530200

Estrogen action via the G protein-coupled receptor, GPR30: stimulation of adenylyl cyclase and cAMP-mediated attenuation of the epidermal growth factor receptor-to-MAPK signaling axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411530200

Phosphatidylinositol 3-kinase coordinately activates the MEK/ERK and AKT/NFkappaB pathways to maintain osteoclast survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411530200

IL-1alpha stimulation of osteoclast survival through the PI 3-kinase/Akt and ERK pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411530200

Tumor necrosis factor-alpha supports the survival of osteoclasts through the activation of Akt and ERK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411530200

Regulation of interleukin-6, osteoclastogenesis, and bone mass by androgens. The role of the androgen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411530200

Repression of the Interleukin-6 Promoter by Estrogen Receptor Is Mediated by NF-κB and C/EBPβ

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411530200

17 beta-Estradiol inhibits expression of human interleukin-6 promoter-reporter constructs by a receptor-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411530200

Estrogen blocks M-CSF gene expression and osteoclast formation by regulating phosphorylation of Egr-1 and its interaction with Sp-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411530200

Estrogen decreases TNF gene expression by blocking JNK activity and the resulting production of c-Jun and JunD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411530200

Estrogen deficiency induces bone loss by enhancing T-cell production of TNF-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411530200

Human giant cell tumors of the bone (osteoclastomas) are estrogen target cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411530200

The Src signaling pathway regulates osteoclast lysosomal enzyme secretion and is rapidly modulated by estrogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411530200

Estrogens suppress RANK ligand-induced osteoclast differentiation via a stromal cell independent mechanism involving c-Jun repression

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411530200

A crucial role for thiol antioxidants in estrogen-deficiency bone loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411530200

JNK1 modulates osteoclastogenesis through both c-Jun phosphorylation-dependent and -independent mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411530200

21 January 2018

Identifiers

DOI

10.1074/JBC.M411530200

1 reference

10 December 2017

1 reference